Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)

NCT00724295 · clinicaltrials.gov ↗

COMPLETED

Status

1077

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C

Interventions

DRUG: peginterferon alfa-2b
DRUG: ribavirin

Sponsor

Merck Sharp & Dohme LLC